Skokhrukh P Abdullaev
4PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Aug 27, 2025
Genetic Modulation of Silodosin Exposure and Efficacy: The Role of CYP3A4, CYP3A5, and UGT2B7 Polymorphisms in Benign Prostatic Hyperplasia Management.Shokhrukh P Abdullaev, Maksim N Shatokhin, Pavel O Bochkov
|Feb 13, 2025
CYP2D6 genetic polymorphisms impact on tamsulosin efficacy and safety in patients with benign prostatic hyperplasia.Shokhrukh Abdullaev, Maksim Shatokhin, Ivan Sychev
|Sep 01, 2023
Effects of CYP2D6 allelic variants on therapy with tamsulosin in patients with benign prostatic hyperplasia.Skokhrukh P Abdullaev, Maksim N Shatokhin, Svetlana N Tuchkova
|Apr 19, 2020
Clinically relevant pharmacogenetic markers in Tatars and Balkars.Shokhrukh Pardaboevich Abdullaev, Karin Badavievich Mirzaev, Irina Sergeevna Burashnikova
Pageof 1
Frequent Collaborators
2 joint publications
Pavel O Bochkov
2 joint publications
Sherzod P Abdullaev
1 joint publications
Maksim Shatokhin
1 joint publications
Ivan Sychev
1 joint publications
Aleksandr Krasnov
1 joint publications
Svetlana Tuchkova
1 joint publications
Oleg Teodorovich
1 joint publications
Oleg Loran
1 joint publications
Dmitry Sychev
